and validation. Another interesting aspect of thoracic EIT is its ability to record and filter pulsatile signals of perfusion. Although promising studies have been published on this topic, this technology is still at its beginnings. A breakthrough would allow simultaneous visualization of both regional blood flow and regional ventilation – enabling clinicians to locate and react upon physiological shunts caused by regional mismatches of lung ventilation and perfusion with associated hypoxemia. Breast (MF-EIT) EIT is being investigated in the field of breast imaging as an alternative/complementary technique to mammography and magnetic resonance imaging (MRI) for breast cancer detection. The low specificity of mammography and of MRI result in a relatively high rate of false positive screenings, with high distress for patients and cost for healthcare structures. Development of alternative imaging techniques for this indication would be desirable due to the shortcomings of the existing methods: ionizing radiation in mammography and the risk of inducing nephrogenic systemic fibrosis (NSF) in patients with decreased renal function by administering the contrast agent used in breast MRI, Gadolinium. Literature shows that the electrical properties differ between normal and malignant breast tissues, setting the stage for cancer detection through determination of electrical properties. An early commercial development of non-tomographic electrical impedance imaging was the T-Scan device which was reported to improve sensitivity and specificity when used as an adjunct to screening mammography. A report to the United States Food and Drug Administration (FDA) describes a study involving 504 subjects where the sensitivity of mammography was 82%, 62% for the T-Scan alone, and 88% for the two combined. The specificity was 39% for mammography, 47% for the T-Scan alone, and 51% for the two combined. Several research groups across the world are actively developing the technique. A frequency sweep seems to be an effective technique for detecting breast cancer using EIT. United States Patent US 8,200,309 B2 combines electrical impedance scanning with magnetic resonance low frequency current density imaging in a clinically acceptable configuration not requiring the use of gadolinium chelate enhancement in magnetic resonance mammography. Cervix (MF-EIT) In addition to his pioneering role in the development of the first EIT systems in Sheffield professor Brian H. Brown is currently active in the research and development of an electrical impedance spectroscope based on MF-EIT. According to a study published by Brown in 2000, MF-EIT is able to predict [Cervical intraepithelial neoplasia] (CIN) grades 2 and 3